Auswahl der wissenschaftlichen Literatur zum Thema „Sustained release lithium“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Sustained release lithium" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Sustained release lithium"
Astruc, B., P. Petit und M. Abbar. „Overdose with sustained-release lithium preparations“. European Psychiatry 14, Nr. 3 (Juni 1999): 172–74. http://dx.doi.org/10.1016/s0924-9338(99)80737-8.
Der volle Inhalt der QuelleBosse, George M., und Thomas C. Arnold. „Overdose with sustained-release lithium preparations“. Journal of Emergency Medicine 10, Nr. 6 (November 1992): 719–21. http://dx.doi.org/10.1016/0736-4679(92)90531-w.
Der volle Inhalt der QuelleHeim, W., H. Oelschläger, J. Kreuter und B. Oerlinghausen. „Liberation of Lithium from Sustained Release Preparations“. Pharmacopsychiatry 27, Nr. 01 (Januar 1994): 27–31. http://dx.doi.org/10.1055/s-2007-1014270.
Der volle Inhalt der QuelleHrdlička, M., und P. Ševčík. „Lethal lithium poisoning with sustained-release preparations“. British Journal of Psychiatry 171, Nr. 6 (Dezember 1997): 586. http://dx.doi.org/10.1192/bjp.171.6.586a.
Der volle Inhalt der QuelleKang, Hyeonmuk, Taehee Kim, GyuSeong Hwang, GeunHyeong Shin, Junho Lee und EunAe Cho. „Sustained Release of AgNO3 Additive in Carbonate Electrolytes for Stable Lithium Metal Anodes“. ECS Meeting Abstracts MA2022-01, Nr. 4 (07.07.2022): 526. http://dx.doi.org/10.1149/ma2022-014526mtgabs.
Der volle Inhalt der QuelleFriedberg, Richard C., Daniel A. Spyker und David A. Herold. „Massive overdoses with sustained-release lithium carbonate preparations: pharmacokinetic model based on two case studies“. Clinical Chemistry 37, Nr. 7 (01.07.1991): 1205–9. http://dx.doi.org/10.1093/clinchem/37.7.1205.
Der volle Inhalt der QuelleBorrás-Blasco, Joaquín, Ana Esther Sirvent, Andrés Navarro-Ruiz, Ana Murcia-López, Isabel Romero-Crespo und Ricardo Enriquez. „Unrecognized Delayed Toxic Lithium Peak Concentration in an Acute Poisoning with Sustained Release Lithium Product“. Southern Medical Journal 100, Nr. 3 (März 2007): 321–23. http://dx.doi.org/10.1097/01.smj.0000257619.25995.c4.
Der volle Inhalt der QuelleLlabrés, M., und J. B. Fariña. „Gastro-intestinal bioavailability assessment of commercialy prepared sustained-release lithium tablets using a deconvolution technique“. Drug Development and Industrial Pharmacy 15, Nr. 11 (Januar 1989): 1827–41. http://dx.doi.org/10.3109/03639048909052403.
Der volle Inhalt der QuelleGregson, P. J., und I. Sinclair. „Deviant Crack Path Behaviour of Aluminium-Lithium Alloy AA8090 Plate“. Proceedings of the Institution of Mechanical Engineers, Part G: Journal of Aerospace Engineering 210, Nr. 2 (April 1996): 117–21. http://dx.doi.org/10.1243/pime_proc_1996_210_352_02.
Der volle Inhalt der QuelleGai, M. N., A. M. Thielemann und A. Arancibia. „Effect of three different diets on the bioavailability of a sustained release lithium carbonate matrix tablet“. Int. Journal of Clinical Pharmacology and Therapeutics 38, Nr. 06 (01.06.2000): 320–26. http://dx.doi.org/10.5414/cpp38320.
Der volle Inhalt der QuelleDissertationen zum Thema "Sustained release lithium"
Couffignal, Camille. „Variabilité de la réponse pharmacologique, modélisation et influence des plans expérimentaux“. Electronic Thesis or Diss., Université Paris Cité, 2021. http://www.theses.fr/2021UNIP5250.
Der volle Inhalt der QuelleThe increasing number of patients with chronic diseases, most of whom are subject to long-term treatment, justifies the exploration and characterisation of phenotypic and genetic factors of pharmacological response. The identification and estimation of the pharmacokinetic-pharmacodynamic variability involved in the response to a treatment are essential steps in this exploration to achieve precision medicine. We studied the re-introduction of β-blockers after cardiac surgery in a prospective multicentre cohort of patients receiving chronic β-blocker therapy and who underwent cardiac surgery. With a landmark analysis, we have shown the efficacy of reintroducing β-blockers 72 hours after cardiac surgery on the occurrence of atrial fibrillation. We modelled, using a population approach, the serum, erythrocyte and urine concentration data of once-daily sustained-release lithium in bipolar patients undergoing treatment for at least two years. A clinical research protocol was then written, with an optimization of sampling times, based on the pharmacokinetic model obtained, to characterise inter- and intra-individual variability and to identify predictive factors of the prophylactic response to lithium. We evaluated, by simulation, the impact of the crossover versus parallel design, as well as the choice of statistical model during the analysis, in pharmacogenetic studies evaluating two treatments (candidate and reference) when a genetic polymorphism increases or not the efficacy of the candidate treatment compared to the reference. The results of this simulation study show that the choice of the model and the choice of the experimental design strongly affect not only the type I error and the power to detect a gene-treatment interaction, but also the correct allocation of the treatment. This work reinforces the need to use adequate statistical tools and experimental designs in the analysis of a clinical trial or pharmacoepidemiological study to characterize and quantify the variability of the pharmacological response